...
首页> 外文期刊>Frontiers in Molecular Biosciences >The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
【24h】

The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties

机译:一些轴配体对钌 - 酞菁配合物的影响:化学,光化学和光生物学

获取原文

摘要

This work presents a new procedure to synthesize ruthenium-phthalocyanine complexes and uses diverse spectroscopic techniques to characterize trans-[RuCl(Pc)DMSO] (I) (Pc = phthalocyanine) and trans-[Ru(Pc)(4-ampy)2] (II) (4-ampy = 4-aminopyridine). The triplet excited-state lifetimes of (I) measured by nanosecond transient absorption showed that two processes occurred, one around 15 ns and the other around 3.8 μs. Axial ligands seemed to affect the singlet oxygen quantum yield. Yields of 0.62 and 0.14 were achieved for (I) and (II), respectively. The lower value obtained for (II) probably resulted from secondary reactions of singlet oxygen in the presence of the ruthenium complex. This work also investigates how axial ligands in the ruthenium-phthalocyanine complexes affect their photo-bioactivity in B16F10 murine melanoma cells. In the case of (I) at 1 μmol/L, photosensitization with 5.95 J/cm2 provided B16F10 cell viability of 6%, showing that (I) was more active than (II) at the same concentration. Furthermore, (II) was detected intracellularly in B16F10 cell extracts. The behavior of the evaluated ruthenium-phthalocyanine complexes point to the potential use of (I) as metal-based drug in clinical therapy. Changes in axial ligands can modulate the photosensitizer activity of the ruthenium phthalocyanine complexes.
机译:该工作呈现了合成钌 - 酞菁配合物的新方法,并使用不同的光谱技术来表征转载(PC)DMSO](I)(PC =酞菁)和转发 - [Ru(PC)(4-Ampy)2 ](ii)(4- ampy = 4-氨基吡啶)。通过纳秒瞬态吸收测量的(I)测量的三重态激发状态寿命显示,发生了两种方法,在15ns左右约3.8μs。轴向配体似乎影响单线氧量子产率。 (I)和(II)分别达到0.62和0.14的产率。 (ii)获得的较低值可能是由于单线鎓络合物存在下单线氧的二次反应导致。该工作还研究了钌 - 酞菁复合物中的轴向配体如何影响B16F10鼠黑素瘤细胞中的光学生物活性。在(i)的情况下,在1μmol/ L的情况下,具有5.95J / cm2的光敏化提供了6%的B16F10细胞活力,显示(I)比(II)更高的浓度。此外,在B16F10细胞提取物中检测到(II)。评估的钌 - 酞菁复合物的行为指向(I)作为临床治疗中的金属药物的潜在用途。轴向配体的变化可以调节钌酞菁配合物的光敏剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号